Intended for healthcare professionals

Research News

Dabigatran “non-inferior” to warfarin, but only just

BMJ 2013; 346 doi: (Published 27 February 2013) Cite this as: BMJ 2013;346:f1219

OpenUrlCrossRefPubMedWeb of Science

New oral anticoagulants offer the prospect of stability and convenience for people needing treatment for a recent deep vein thrombosis or pulmonary embolus. They might also allow longer term treatment to prevent recurrence, and Boehringer Ingelheim recently reported results from …

View Full Text

Log in

Log in through your institution


* For online subscription